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Abstract
A way to avoid or minimize the side effect that could result in drug delivery to 
cells with increased efficiency and performance in the health rehabilitation process 
is to use biocompatible and biodegradable drug carriers. These are essentially 
biomaterials that are metallic, ceramic, or polymeric in nature. The sources of these 
materials must be biological in its entire ramification. The classification, synthesis, 
processing, and the applications to which these materials are put are the essential 
components of having suitable target cell drug carriers. This chapter will be devoted 
to discussing biomaterials suitable as drug carrier for use in the health-related 
 matters of rehabilitation.
Keywords: biomaterials, drug carriers, cell, drug delivery, health, synthesis, target
1. Introduction
The quest for controlled drug release emanating from side effects associ-
ated with the application and delivery of conventional drugs has necessitated 
the need for materials that can transport drugs to target site without difficulty 
or problem during and after delivery. Normally, drugs are delivered repeatedly 
on prescription to the body in measures that will bring about remediation and 
quick recovery to the patient during the treatment period. In this wise, drug 
concentration levels will increase and when above the body’s tolerance level, the 
problems associated with over therapeutic concentrations could occur that could 
result into toxic side [1]. It is also possible that the drug release rate is so fast that 
therapeutic actions are no longer effective owing to low drug concentrations at 
the delivery site, which may occur through drug metabolism, degradation, and 
transport out of the target [1]. Consequently, this phenomenon would result in 
drug wastage and transport medium loss with high risk offside effects on sur-
rounding body cells, tissues, and organs. The solution to these problems is to 
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have drug carriers that can provide controlled release rate to the target and would 
allow for complete therapeutic rehabilitation before degradation and transport 
of excess concentration of drug and carrier medium [2]. The drug and its carrier 
in form of capsules are orally administered and may be formulated for parenteral 
administration [3]. The drug release rate of the capsule can be controlled via the 
use of cellulose coatings exhibiting slow dissolution, incorporation of drug-
complexing elements or compounds which hinder fast dissolution of drug, use 
of compressed tablets, and the inclusion of emulsion and suspensions. Materials 
that can permit drug release without changing or decaying over time with longer 
therapeutic windows (days to years) are required. These carries are such that 
they can be injected and/or implanted directly to target diseased tissues/cells 
for enhancing delivery efficiency [4]. To achieve target drug delivery, the use of 
affinity ligands deposited on biomaterial surfaces to allow for a set retention and 
usage by infirm tissues and cells have been employed [5]. The design of biomate-
rials for drug carriers aside permitting surface modification using ligands should 
also shield drugs from speedy break down and/or degeneracy within the target 
site.
Thus, the design parameters include: (i) the encapsulation of the sufficient 
drug of the biomaterial for lengthened release pattern to achieve efficient healing, 
(ii) sustaining drug stability for effective therapeutics through body transport and 
at the target site while preserving biological activity, (iii) predictable release rate 
in the therapeutic period from days to years, (iv) biomaterials and its degradation 
products must be biocompatible and nontoxic within the body, and (v) the cost of 
biomaterial synthesis and/or fabrication.
2. Health implications of materials used for drug delivery
Lupron Depot, a poly (lactic-co-glycolic) acid (PLGA) microsphere encap-
sulating the hormone leuprolide, for the treatment of advanced prostate can-
cer, and endometriosis [6], PLGA, poly (lactic acid) (PLA), and polyglycolic 
acid (PGA) materials have FDA approval as micro-particle depot systems as 
they versatile in controlling material biodegradation time, are biocompatible 
with nontoxic natural degradation products (lactic acid and glycolic acid). 
Clinical nanoparticles with FDA approval for cancer nanomedicine treatment of 
Kaposi’s sarcoma (approved 1995) and for recurrent ovarian cancer (approved 
1998) is Doxil [7], a poly (ethylene glycol) (PEG) coated (i.e., PEGylated) 
liposomal encapsulating the chemotherapeutic doxorubicin [8]. This enhances 
circulation half-life and tumor uptake of the drug, and also reduces its toxi-
cological activity in patients in comparison to the use of free drug [9]. Other 
approved nanoparticle drug carriers include Marqibo, a liposomal encapsulating 
vincristine for rare leukemia treatment [10] and Abraxane an albumin-bound 
paclitaxel nanoparticle for the treatment of breast cancer [11]; Duragesic-
transdermal drug delivery system patch containing the opioid fentanyl embed-
ded within an acrylate polymer matrix, in the treatment of chronic pain [12]; 
and OROS, an osmotically controlled oral drug delivery technology, incorpo-
rated into several oral delivery products including Concerta [13]. Implantable 
biomaterials used include the Gliadel wafer, which consists of dime-sized wafers 
comprised of the chemotherapeutic agent carmustine and a polymer matrix 
made of poly (carboxyphenoxy-propane/sebacic acid), which are surgically 
inserted into the brain post-tumor resection [14–16] use as an adjunct to surgery 
in patients with recurrent glioblastoma multiforme.
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3. Bioresponsive polymers: from design to implementation
An ideal therapeutic drug is expected to treat or cure a disease without resulting 
to any side effects [17–19]. However, this goal has not been achieved. Many che-
motherapeutics are found to destroy both cancerous and healthy cells within the 
vicinity of the target site [20]. An efficient chemotherapeutics would administer 
drug, directly to diseased cell populations. Polymers have been found to permit the 
creation of “responsive” materials within the host environment and can be for-
mulated with drugs to control release [21]. This polymer attribute is due to tuning 
propensity of the molecular weight of polymers that can be controlled via monomer 
stoichiometry using controlled polymerization strategies like ATRP [22], RAFT 
[23], NMO [24], and ROMP [25]. A bioresponsive material is one that can respond 
to a specific “trigger” inside or outside of the human body. Because the body have 
unique pathological parameters as pH gradients, temperatures, enzymes, small 
molecules, etc., the creation of materials that will respond to physiological altera-
tions in both space and time are required.
Triggers include chemical, biological, and physical stimuli [26, 27], the chemical 
and biological ones are intrinsic to the body, while the physical stimuli are extrinsic 
to the body can thus be used to quicken sole drug delivery.
4. Redox-sensitive polymers
Bioresponsive materials are initiated by redox potential difference tissue 
environment and its surrounding [28]. There are materials that can respond to 
both oxidation and reduction triggers, which are incorporated into responsive 
polymers, e.g., diselenides with chemical structure like those of disulfides 
[29]. Diselenides allows for alternative triggers within nano-biotechnology 
 applications [30].
5. pH-responsive polymers
The constituents of the human body such as tissues, fluids, and organelles have 
varied pH values. Areas like stomach, vagina, and lysosomes display acidic pHs 
(<7); ocular surface (7.1), the blood (≈7.4), and bile (7.8) [21]. Owing to these varied 
Figure 1. 
Schematic illustration of drug loading and controlled release of poly (ethylene glycol) [34]. DOX, doxorubicin; 
PAE, poly (β-amino esters); PEG, poly (ethylene glycol).
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pHs of systems and organs in the body improvement in the efficacy and precision 
of therapeutic molecules will necessitate the design of polymeric drug delivery 
systems that are pH specific. pH-responsive materials have been useful in nucleic 
acid delivery, doxorubicin delivery, and taste masking [31, 32]. The target treatment 
of tumors has been enhanced using the pH-responsive materials. Such known target 
delivery includes multifunctional acid sensitive nanocomposites for anticancer 
drugs and acid-responsive poly(ethylene glycol) derivatives [33] for the controlled 
release of therapeutics in tumor target treatment (Figure 1).
6. Hydrolysis and enzymatically responsive polymers
Hydrolysis prone materials can be degraded by body fluid via nucleophilic addi-
tion of water into an electrophilic functional group on a polymer. The electrophilic 
functional groups often used on polymers include esters and anhydrides [35]. The 
Gliadel wafer consisting of chemotherapeutic Carmustine impregnated within a 
polyanhydride material has been demonstrated as hydrolysis-sensitive materials for 
drug delivery [36] in the treatment of brain tumors. Enzyme-responsive polymers 
such as matrix metallo-proteins, hyaluronidases, phospholipases, and prostate-
specific antigen [21] have been incorporated into polymers for target drug delivery 
in areas like tumor imaging, doxorubicin delivery, and minimization of inflamma-
tion in the colon [37].
7. Temperature-responsive polymers
Another drug delivery vehicle is the temperature-sensitive polymers that can 
operate at both human body temperature of 37°C and at ambient temperature such 
as 25°C [38]. These polymers include poloxamers, poly(N-alkyl acryl amides), 
poly(N vinyl caprolactams), cellulose, xyloglucan, and chitosan. These thermo-
responsive polymers can be modified via [39] varying the ratio of monomers, end-
group modifications, and post-polymerization modifications to make them suitable 
for varying applications [40].
8. Magnetic-responsive polymers
Magnetic-responsive polymers are therapeutic drug-loaded polymers that work 
under the influence of magnetic resonance imaging (MRI) to delivery its drug to 
the target [41]. These include the following: systematic release of dopamine from 
alginates impregnated with magnetic beads; targeted plasmid delivery to the lung 
via chitosan nanoparticles; and insulin delivery [42].
9. Light-responsive polymers
Light-responsive polymers are used as external drug delivery systems that use 
noninvasive and painless techniques [26, 43–48] as drugs are delivered by light 
UV- and visible-wavelength irradiation stimulation. In this technique, a remote-
activated approach without direct patient contact is used [49]; this includes the 
release of drugs from a light-responsive azobenzene modified amphiphilic block 
copolymer to target melanoma cells [50].
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10. Swelling and contracting polymers
There are polymers that can swell or shrink in response to external stimuli 
[51]. This phenomenon can have stemmed from changes in porosity occasioned as 
ionic cross-linking molecules are leached, resulting in alteration of the diffusion 
pathways for sensing molecules. Alginate is a commonly employed polymer that is 
isolated from seaweed, is relatively biocompatible, and has been used for sus-
tained delivery of vascular endothelial growth factor (VEGF) to a target within 
the body.
11. Biomaterial-based drug delivery systems
While a limited number of affinity-based delivery systems have been developed 
for the delivery of neurotrophic factors, we also examine the broad spectrum of 
reservoir-based delivery systems, including microspheres, electrospun nanofibers, 
hydrogels, and combinations of these systems.
Drug delivery systems transport biological active agents, such as growth fac-
tors and genetic material, into the desired location to promote beneficial effects 
for the treatment of diseases and disorders [52], osmotic pumps for the delivery of 
neurotrophic factors [53] to target site, affinity-based delivery systems (ABDS) in 
which drug loading and controlled release are achieved through the interactions of 
therapeutic drug and the delivery system, and reservoir-based delivery systems, 
where a polymer structure encapsulates the drug while its release is controlled via 
the material properties.
12. Affinity-based delivery systems (ABDS)
ABDS operate through the noncovalent interactions between device mate-
rial and target drug [54] in a similar pattern to the interactions that occur in the 
extracellular matrix where the delivery of proteins and other biomolecules are 
controlled [55]. ABDS include molecular imprinting, cyclodextrin-based delivery, 
and heparin-based delivery [56]. Molecular imprinting uses polymer networks 
synthesized via a precursor molecule that is removed to reveal an imprint that 
acts as an affinity binding zone. In cyclodextrin-based delivery systems, small 
hydrophobic drugs are attracted to the hydrophobic center of an oligosaccharide 
cyclodextrin torus, which permits the complexes formation with enhanced 
solubility when compared to the drug itself. ABDS is observed to be superior to 
traditional reservoir-based systems as the release characteristics are dependent on 
the activities occurring between the drug and the matrix in a way not affected by 
the matrix properties [57].
13. Reservoir-based delivery systems (RBDS)
Reservoir-based delivery systems (RBDS) are porous with drug release rate con-
trolled by diffusion [58]. In RBDS, the drug is immersed or dissolved in a polymer 
solvent/reservoir. The drug penetrates via the biodegradable polymer structure to 
control the initial release followed by another release as surface and bulk erosion 
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occurs in polymer reservoir. RBDS include nanogels, nanoparticles, micelles, 
hydrogels, microspheres, and electrospun nanofibers.
14. Microspheres
Microspheres are usually used as controlled drug release systems for stereo-
tactic injections to isolated disease or injury sites in medicine and pharmacol-
ogy [59]. Drugs like neurotransmitters, hormones, and neurotrophic factors 
have been encapsulated using microspheres obtained from biodegradable poly-
mers [60]. These polymers include poly(lactic acid) (PLA), poly(glycolic acid) 
(PGA), and poly(ε-caprolactone) (PCL). Microsphere-based drug delivery uses 
localized surgical injection to circumvent the blood-brain barrier; this is better 
in performance to orthodox methods like intravenous injection and oral drug 
delivery. The parameters of the microsphere such as the particle size, polymer 
degradation rate, and method of erosion (bulk versus surface degradation) can 
be utilized to control the rate of drug delivery rates [61]. PCL has been found 
useful as a microsphere for the carrier of sustained long period drug delivery as 
it demonstrates the slowest degradation rate [62]. The double emulsion method 
is often used in synthesizing of microspheres. The method involves dissolving 
the desired polymer in a nonpolar solvent to form an oil emulsion. The hydro-
philic compound that is to be encapsulated is dissolved in an aqueous solution 
and then emulsified with the dissolved polymer-solvent solution to give a 
water-in-oil emulsion. After this the solvent evaporates, the polymer solidifies 
as it forms microspheres that encapsulated the inner aqueous  
solution [63].
15. Electrospun nanofibers
Electrospinning process involves the application of an electric potential to 
draw out thin nanometer to micrometer diameter polymer fibers (natural or 
synthetic). A viscous solution of the polymer is prepared (at room or elevated 
temperature), then pumped via a spinneret nozzle (positive terminal) into an 
electric field such that the applied force due to the high voltage counters the 
surface tension leading to the formation of fiber droplets onto a collector plate 
that serves as negative terminal. The nanofibers produced are often used as drug 
based-reservoir delivery systems as the pores in the matrix serves as receptive sites 
for bioactive agents [64]. This fiber production process advantages include surface 
flexibility with respect to function or application, reduced initial burst release, 
and the possibility of producing different fiber configuration depending on 
usage [65]. Drugs are embedded in the pores of electrospun nanofibers by emul-
sion electrospinning; the target drug is dissolved in a desired polymer solution 
[64] such as in diclofenac sodium (DS) and human serum albumin (HSA) [66]. 
Electrospun nanofibers show some draw backs that include formation of drug 
aggregates during encapsulation along nonsmooth fibers, maintaining uniform 
fiber size distribution, the use of toxic solvents to form polymer-drug emulsion 
in drug delivery and its attendant health concerns. Despite these drawbacks, 
advances in the development of less toxic electrospun fibers, which contain 
extracellular matrix components such as keratin and collagen, have been devel-
oped for wound healing application. The biocompatibility potential of PVA with 
the bioactive nature of keratin, CoQ10, and antimicrobial mupirocin has been 
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evaluated for wound care due to its ability to support the growth of keratinocytes 
and hasten skin regeneration [67].
16. Hydrogels
Hydrogel is a hydrophilic network of cross-linked polymer chains with 
swelling capability but does not dissolve in aqueous solution in the presence of 
water to create a three-dimensional gel-like structure. The synthesis of hydrogels 
is through polymerization [68], its properties, and drug release mechanism 
that depend on the polymer type used. The mechanisms involved in the drug 
delivery of hydrogel may be diffusion controlled, chemical controlled, swelling 
controlled, and modulated release systems. The use of acetyl-(Arg-Ala-Asp-
Ala)4-CONH2 self-assembling peptide hydrogel to carry model factors such as 
lysozyme, trypsin inhibitor, BSA, and IgG [69] reveals the potential of these 
hydrogels carriers of therapeutic agents with the preservation of protein activity. 
An agarose hydrogel has been found capable of delivering sustained bioactive 
lysozyme release [70] and was used for the local delivery of BDNF in adult rat 
models.
17. Surface-modified biomaterials
The biomaterial surface chemistry and topography impact protein adsorp-
tion, cell interaction, and host site response. Monocyte adhesion in vitro [71] have 
been shown to be altered by its surface chemistry, while in vivo surface chemistry 
does not significantly influence the foreign body reaction. Polymeric, ceramic, or 
metallic-based biomaterials exhibit variability in surface properties such as hydro-
philic to hydrophobic; hard to soft in vivo [72].
18. Surface specificity
Cell adhesion to adsorbed proteins is achieved via integrin and other 
 receptors in the cell membrane and the occurrence of this triggered  
intracellular signaling events. Thus, the control of protein adsorption on 
biomaterials surfaces is crucial to controlling and directing cell responses. 
Oligopeptides with specific binding sites have been incorporated to control cell 
adsorption to the protein surface and these include short oligopeptide, e.g., 
adhesive oligopeptide is an arginine-glycine-aspartic acid (or RGD) [73] that is 
found in a number of different extracellular matrix proteins, such as fibronectin 
[74], laminin [75], collagen [76], and vitronectin [77]. Short oligopeptides are 
less expensive, easy to synthesize, and has greater flexibility for surface modifi-
cation compared to bulky and labile intact proteins. To a surface modified using 
nonfouling PEG (99%) and RGD (1%), the protein adsorption was minimal 
(2 ng/cm2) leaving the sufficient RGD sites for fibroblast cell adhesion [78]. 
Structure and conformation of oligopeptides influence modulating cell adhe-
sion as demonstrated with the use of immobilized cyclic RGD peptide which 
increased human bone marrow stromal cell adhesion to that of linear RGD 
peptides [79] (Table 1).
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S/No. Drug delivery 
systems
Biomaterial API Significance of the study Reference
ORAL DRUG DELIVERY SYSTEMS
Silk 
Nanoparticles
Silk and fibrin Celecoxib and curcumin Silk fibroin nanoparticles were seen to promote anti-inflammatory properties 
of celecoxib or curcumin and could be exploited for oral osteoarthritis 
management since a controlled drug release was achieved by varying the drug 
loading
[80]
Electrospun 
fibers
Polylactic acid Metronidazole PLA nanofibers associated with metronidazole (MNZ) were used to control 
microbiological proliferation during periodontitis treatment, inhibiting bacteria 
growth during the treatment
[81]
OCULAR DRUG DELIVERY SYSTEMS
Nanocomposite 
hydrogel
Hyaluronic acid Latanoprost The hyaluronic acid nanocomposite hydrogels, with controlled degradation 
properties and sustained release, could serve as potential drug delivery systems 
for many ocular diseases as they controlled the release of latanoprost in vitro
[82]
Hydrogel 
contact lens
Silicone Ofloxacin and 
Chloramphenicol
The drug release from the lenses was directly proportional to the amount of 
drug loaded and the lenses at the different loading concentrations showed 
transmittance of 95–97%. The silicone hydrogel contact lenses can be used to 
control drug delivery to the eye and is an alternative ocular delivery technique in 
the treatment or prevention of corneal infections
[83]
PULMONARY DRUG DELIVERY SYSTEMS
Porous particles Poly(lactide-co-
glycolide) (PLGA)
Celecoxib Large porous celecoxib-PLGA microparticles prepared using supercritical fluid 
technology exhibited sustained drug delivery and antitumor efficacy, without 
causing any significant toxicity
[84]
Nanoparticles Nanopolymeric 
particles consisting 
of hydroxyl propyl 
methylcellulose 
(HPMC), poly-
vinylpyrrolidone (PVP)
Fluticasone The in vitro antibacterial studies showed that HPMC-PVP-FLU nanoparticles 
displayed superior effect against Gram-positive bacteria compared to the 
unprocessed FLU and positive control
[85]
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IV IMPLANT DRUG DELIVERY SYSTEMS
Silk disc 
implants
Silk fibrin IgG antibody or human 
immunodeficiency 
virus (HIV) inhibitor 
5P12-RANTES
SF was formulated into insertable discs that can encapsulate either IgG antibody 
or human immunodeficiency virus (HIV) inhibitor 5P12-RANTES. The water 
vapor annealing showed a sustained release for 31 days and this released protein 
could inhibit HIV infection in both blood and human colorectal tissue
[86]
Bone 
biomaterials 
implant
Hydroxyapatite Doxorubicin-loaded 
cyclodextrin
Hydroxyapatite-cyclodextrin-doxorubicin chemotherapeutic strategy enhanced 
the drug-targeting effect on tumor cells while protecting the more sensitive 
healthy cells after implantation. A successful integration of such a drug delivery 
system might allow healthy cells to initially survive during the doxorubicin 
exposure period
[87]
V SYSTEMIC DRUG DELIVERY
Polylactide 
scaffold 
hydrogel 
injections
Cholesterol-modified 
poly(ethylene 
glycol)–polylactide
Chondrocytes The formulation shows lower critical gelation temperature, higher mechanical 
strength, larger pore size, better chondrocyte adhesion, and slower degradation 
compared to plain polylactide scaffold gels. The hydrogel serves as a promising 
chondrocyte carrier for cartilage tissue engineering and gives an alternative 
solution to surgical cartilage repair
[88]
ANG-(1–7) 
functionalized 
plant 
chloroplast
Lyophilized lettuce cells 
(ACE2/ANG-(1–7))
Lyophilized lettuce cells 
(ACE2/ANG-(1–7))
Toxicology studies showed that both male and female rats tolerated ~10-fold 
ACE2/ANG-(1–7) higher than efficacy dose. The efficient attenuation of 
pulmonary arterial hypertension with no toxicity augurs well for the clinical 
advancement of the first oral protein therapy to prevent/treat underlying 
pathology for this disease.
[89]
VI VAGINAL DRUG DELIVERY SYSTEMS
Organogel Palm oil and hyaluronic 
acid
Maraviroc There was a 2.5-fold increase in the percentage of maraviroc release in the 
presence of hyaluronidase, hence the effectiveness of hyaluronidase enzyme 
acting as a trigger. This shows the potential use of palm oil/hyaluronic acid-based 
organogel for the vaginal delivery of anti-HIV microbicide for HIV prevention
[90]
Vaginal rings Silicone matrix polymer Dapivirine A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 
infection among African women, with increased efficacy in subgroups with 
evidence of increased adherence
[91]
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VII TOPICAL DRUG DELIVERY SYSTEMS
Electrospun 
fibers
Polylactic acid and 
collagen
Collagen and silver 
sulfadiazine
The electrospun fibers were nontoxic to the cells and provided favorable 
substrates for the neonatal epidermal keratinocytes cells to undergo cell 
attachment and proliferation, hence its potential for use in chronic wound 
management
[92]
Hydrogel Polyvinyl alcohol and 
carbopol
Diclofenac diethylamine In vitro skin permeation for 10 h showed that the enhancement ratios of the flux 
of diclofenac was higher compared to the marketed formulations. The study 
highlighted the advantage of the experimental transdermal hydrogel over the 
hydrogel with microsized drug particles
[93]
Table 1. 
Drug delivery systems showing the significance of the biomaterials utilized in delivering active pharmaceutical ingredients at their biological target site.
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19. Nonfouling surfaces
Poly (ethylene glycol) (PEG), or poly(ethylene oxide) (PEO) having nonfouling 
surfaces demonstrates protein and cell resistance capabilities. PEG have been attached 
to materials in such a manner to render them nonfouling through processes like covalent 
immobilization, adsorption, or interpenetration. PEG has been covalently attached to 
mussel adhesive protein to form a nonfouling and a sticky segment copolymer [94] with 
gold and titanium surfaces attached to the sticky segment, while the PEG chains occur 
at the new interface. It should be noted that the nonfouling ability/attribute of PEG is 
dependent on the surface chain density that is prone to oxidants damaged. However, the 
use of plasma deposition of tetra ethylene glycol dimethyl ether (tetraglyme) on PEG 
will reduce protein surface adsorption [95]. Other materials with nonfouling surfaces 
include phospholipid surfaces [96] and saccharide surfaces [97], and these biomaterials 
ensure increased compatibility issues between the drug carrier systems and biological 
systems to which they are introduced to elicit a pharmacological activity.
20. Smart biomaterials
Materials which respond to environmental changes are attractive particularly in 
vivo as these can be utilized to control drug release, cell adhesiveness, mechanical 
properties, or permeability. These environmental changes can be brought about by 
stimulants like pH [98], temperature [99], and light [100]. The body employs changes 
in pH to facilitate a range of different processes. For example, along the gastrointesti-
nal track, food is broken down into nutritive substances in the stomach under acidic 
pH ∼ 2 and subsequently absorbed in the small intestine (pH ∼ 7). Patient often 
prefers the oral drug delivery requiring routine, periodic delivery of drugs and for 
effectiveness, the drug must resist the stomach acidic pH. The pH-sensitive materials 
that are mindful of gastrointestinal tract pH variation have been developed to trans-
port drugs successfully through the stomach to the small intestine. Such successful 
materials include pH responsive hydrogels prepared from poly(methacrylic acid) 
grafted with poly(ethylene glycol) (PMAA-g-PEG) that swells in response to pH. For 
instance, the gel shrinks by trapping the drug cargo pH ∼ 2 as interpolymer complexes 
are formed, but at physiological pH ∼ 7, the gel can swell 3–25 times based on its com-
position as it releases its cargo in the target site [101]. Insulin-loaded PMAA-g-PEG gels 
have been orally delivered to diabetic mice with a significant decrease in glucose levels 
as protein function is protected in acidic and digestive enzymes environments [102].
20.1 Self-assembled biomaterials
Self-organization or self-assembly is based on the formation of weak noncovalent 
bonds, like hydrogen, ionic, or Van der Waals bonds or hydrophobic interactions 
[103]. In amphiphilic molecules, there are hydrophobic and hydrophilic segments 
that self-assemble to form nanometer 3D structures like micelles, vesicles, and 
tubules, which depend on the molecule’s length and composition [104–107]. When 
any of these are dispersed in aqueous solvent, the hydrophobic segments agglomer-
ate and water is expelled to produce a well-ordered structure useful in biomedical 
applications. Phospholipid a naturally occurring amphiphilic molecule that is largely 
compose of cell membrane is one such amphiphilic molecules while an oligomer, 
a polymer of amino acids, can be synthesized to have hydrophobic, hydrophilic, 
charged, etc., regions that can self-assemble into a macroscopic hydrogel [108]. The 
self-assembled biomaterials can be engineered for use in nanotechnology, tissue 
engineering for drug and cell carriers.
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21. Controlled drug delivery
Polymers are large molecules formed from simple monomers and may be 
synthetic or biopolymers that are the constituents of living organisms like proteins, 
nucleic acids, and sugars. Biopolymers are active in controlling and regulating many 
biochemical and biophysical functions of living cells, and thus can participate 
in cooperative interactions, resulting in nonlinear response to external stimuli. 
The cooperative interaction mechanism of biopolymers is utilized in producing 
synthetic polymers that are similar in behavior to biopolymers, which are used as 
biomaterials with ability to interface with biological systems for a variety of living 
cells functions.
Polymeric, biodegradable materials are often useful in biomedical applications, 
as the polymers degrade into normal metabolites of the body or eliminated from the 
body with or without further metabolic transformation [109, 110]. Developed poly-
meric biomaterials have physical and chemical properties that are maintained and 
are not tampered with during synthesis. The use of synthetic polymeric biomateri-
als includes artificial corneal substitute, blood contacting devices, hip joint replace-
ments, and formation of intraocular lenses [111, 112]. Biodegradable polymers are 
either natural or synthetic. Natural polymers are derived from natural resources 
and have potential to be considered for biomedical and pharmaceutical applica-
tions owing to biocompatibility, biomimicking environments, unique mechanical 
properties, and biodegradability. Natural polymers are prone to viral infection, 
antigenicity, and unstable material supply, which limit biomedical application. On 
the other hand, synthetic polymers are flexible in synthesis procedure technique 
with excellent reproducibility which made them useful for surgical and short-term 
medical application, orthopedic applications that may slowly transfer the load as it 
degrades [113].
The drug administration into the body is either via an oral or intravenous route with 
repeated administration done to increase concentration and performance. But this may 
reach an extreme level before it declines rapidly especially when the elimination rate 
from the body is high. A too low or too high drug concentration in the body will not 
benefit the patient because of the side effects. This phenomenon then becomes a con-
cern requiring the use of controlled drug release mechanism which can only be offered 
by biomaterials [114]. For controlled drug release, the therapeutic and bioactive agents 
are enveloped or encapsulated in an insoluble biodegradable subnano, nano, micropoly-
mer matrix cavity where the therapeutic agents are released in a controlled fashion.
22. Various drug delivery systems
Widely used drug delivery systems include a liposomal drug delivery system 
[115, 116] that consists of phospholipids, i.e., fatty acid esters and fat alcohol 
ethers of glycerol phosphatides; they are negatively charged at physiological pH 
due to their phosphate groups. Cationic liposomes are prepared using lipid mol-
ecules having a quaternary ammonium head group. Because cellular membranes 
carry negative charges, cationic liposomes interact with these cellular membranes 
[117]. The stability of liposomes in biological environment is improved with steric 
stability that can extend its blood circulation time after being administered [118]. 
Biodegradable polymers are usually used to enhance the steric stability of the lipo-
somes. Natural biodegradable polymers that are suitable for drug delivery systems 
include proteins (collagen, gelatin, albumin, etc.) and polysaccharides (starch, 
dextran, chitosan, etc.) [119].
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22.1 Polysaccharides
Polysaccharides are many monosaccharide repeating units with high molecular 
weight. It is biodegradable, biocompatible, and water soluble which make suitable 
for drug delivery. There are several different types of polysaccharides having differ-
ent functional groups, which are as follows:
22.2 Alginic acid or alginates
Alginic acid is a linear hetero polysaccharide, nonbranched, high-molecular-
weight binary copolymer of (1–4) glycosidic linkage with β-D-mannuronic acid 
and α-L guluronic acid monomers [120, 121]. Natural alginic acid can be obtained 
from the cell walls of brown algae. Its acidic nature helps in its spontaneous forma-
tion of salts and later gels in the presence of divalent cations like calcium ions. This 
occurs by the interaction of divalent cations with guluronic acid blocks present on 
other polysaccharide chains. The gel property paves way for the encapsulation of 
molecules that can act as drugs within alginate gels with negligible side effects. The 
drug delivery mechanism of alginates is hinged on the drug polymer interaction and 
chemical immobilization of the drug on the polymer backbone via reactive carbox-
ylate groups [122–124].
22.3 Starch
Starch, which is a carbohydrate source can be isolated from corn, wheat, potato, 
tapioca, rice, etc., and consists of two glucosidic macromolecules: 20–30% of 
linear molecule—amylase and 70–80% of branched molecule—amylopectin. The 
products of starch processing include thin films, fibers, and porous matrices. It is 
an important polymer for thermoplastic biodegradable materials due to its low cost, 
availability, biocompatibility, biodegradability, and having renewable resources 
[125]. The products of starch degradation include fructose and maltose that are 
low molecular weight sugar [126]. Microspheres from starch have bioadhesive drug 
delivery system potential for nasal delivery of proteins [127].
22.4 Dextran
Dextran is a natural polysaccharide of large glucose molecules with long 
and branched chains of varying lengths from 3 to 2000 Kd at 1,6- and partly at 
1,3-glucosidic linkages. It is synthesized from sucrose via lactic-acid bacteria 
like Leuconostoc mesenteroides, Streptococcus mutans, and lactic acid bacterium 
Lactobacillus brevis. It is colloidal and hydrophilic in nature; it is inert to the in vivo 
environment with no effect on cell viability [128]. Dextran is used as an antithrom-
botic (antiplatelet), to reduce blood viscosity, and as a volume expander in anemia 
[129]. Dextran can be degraded by enzyme dextranase in the colon and thus can 
serve as a colonic drug delivery system.
22.5 Pullulan
Pullulan occurs naturally as linear homopolysaccharide polymer with malto-
triose units of 3-glucose or D-glucopyranose units which are linked by α-(1 → 4) 
glycosidic linkages. It is edible, bland, and tasteless and thus is added to food and 
beverages. It serves as a coating agent in pharmaceutics, breath fresheners, or oral 
hygiene products [130]. Consecutive maltotriose units are linked to one another via 
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α-(1 → 6) glycosidic bond. The pullulan backbone structure is similar to dextran, as 
both are plasma expanders. Pullulan is commercially synthesized via fermentation 
process involving the growth of fungus Aureobasidium pullulans on a carbohydrate 
substrate, which is then harvested. This process is followed by the rupture of cell 
using either an enzyme or a physical force, and pullulan is then extracted via simple 
water extraction method [130]. This method does not constitute any threat to the 
environment and therefore it is ecofriendly. This then makes pullulan suitable as a 
drug delivery vehicle. Pullulan hydrogel micro and nanoparticles are employed in 
oral administration of gastro-sensitive drugs.
22.6 Hyaluronic acid
Hyaluronic acid also a natural occurring negatively charged linear polysaccha-
ride made of repeating disaccharide units of D-glucuronic acid and 2-acetamido-
2-deoxy-D-glucose monosaccharide units. It exists majorly in articular cartilage, 
connective tissues, synovial fluids of mammals and the mesenchyme of developing 
embryos. It is water soluble and forms highly viscous solutions and therefore suit-
able for use as wound dresser as it can act as scavenger for free radicals in wound 
sites to modulate inflammation [131]. Its use in tissue repair application include to 
protect delicate tissue in the eye in removal of cataract, corneal transplantation, and 
glaucoma surgery, as vitreous substitute in retina re-attachment surgery, to relieve 
pain and improve joint mobility in osteoarthritis (knee) patients suffering and 
accelerate bone fracture healing [132].
22.7 Chitin and chitosan
Chitin a natural occurring polysaccharide of 1 → 4 β-linked glycan containing 
2-acetamido-2-deoxy-D-glucose is a component of shells of crustaceans, cell walls 
of fungi, etc. When chitin is deacetylated chitosan a semi-crystalline linear copo-
lymer polysaccharide is produced with (1 → 4) β-linked D-glucosamine and some 
N-acetyl glucosamine groups. The degree of deacetylation (DD) of chitosan may be 
from 70% and 90% and the MW is in between 10 and 1000 k [133]. While chitin 
is insoluble in regular solvents, chitosan is fully soluble in aqueous solutions with 
pH ˂5.0 [134]. Chitosan degrades in vivo enzymatically via lysozyme to nontoxic 
products [134]. Chitosan is easy to process and applied, oxygen permeability, 
water absorptivity, hemostatic property, and ability to induce interleukin-8 from 
fibroblasts. It uses include wound and burn dressing material, drug delivery and 
controlled drug release.
22.8 Polyurethane
Polyurethane is a polymer with a chain of organic units linked by carbamate 
(urethane), which is formed from two or several bi- or higher-functional mono-
mers, one having two or more isocyanate functional groups (–N=C=O) and the 
other with two or more hydroxyl groups (–OH) [135]. It is a material with similar 
elasticity to rubber, possess toughness and durability comparable to metal, and is 
chemically inert. Polyurethane micelles are suitable drug delivery systems.
23. Conclusion
Advances in medical research have led to the exploration of various materials as 
drug carriers for suitable delivery. Biomaterials are currently well explored in recent 
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years as a result of their ubiquitous nature, ease of accessibility, biodegradability, 
and biocompatibility with living tissues. They have been singly used or blended 
with other materials as composites. This chapter has thus discussed the different 
biomaterials with their functionalities in the area of drug release. More biomaterials 
can be explored by processing and characterizations from natural origin to ensure 
effective performance and limit health complications associated with drug release.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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